Medical Department I, University Hospital Marien Hospital Herne, Ruhr-University Bochum, Hölkeskampring 40, 44625 Herne.
J Hypertens. 2024 May 1;42(5):777-782. doi: 10.1097/HJH.0000000000003694. Epub 2024 Feb 19.
Sleep apnea is associated with hypertension. Metaanalyses indicate that treatment of sleep apnea by continuous positive airway pressure (CPAP) reduces blood pressure (BP) by a mean of 3 mmHg. To date, predictors of BP response to CPAP remain incompletely understood. We hypothesized that the magnitude of CPAP-induced BP reduction depends on baseline apnea-hypopnea index (AHI) and the extent of daytime sleepiness.
We performed a retrospective study on the association of BP response to CPAP with polysomnographic readings, intensity of sleepiness (measured by Epworth Sleepiness Scale, ESS), and epidemiologic parameters in 2461 patients with obstructive sleep apnea. BP response was defined as the difference between office BP at polysomonography examinations before and after initiation of CPAP.
Five hundred and fifty-five patients fulfilled all inclusion and exclusion criteria and were included in the analysis. Median monthly CPAP usage was 143.7 h (85.4-204.1 h). BP was significantly higher at baseline than at follow-up (129.9 ± 15.5 vs. 128.3 ± 15.2, P = 0.021) resulting in mean reduction of BP of -1.5 ± 19.2 mmHg. patients with a higher than median baseline AHI (median 21) showed a more pronounced reduction of BP than those with lower AHI (AHI ≥21: 130.5 ± 15.3 vs. 128.6 ± 14.6, P = 0.06; AHI <21: 129.5 ± 15.8 vs. 127.9 ± 15.8, P = 0.18). CPAP therapy led to a significant reduction in sleepiness (8.3 ± 4.8 vs. 6.6 ± 4.5, P < 0.0001). Those subjects with higher than median sleepiness score (ESS ≥8), however, did not show a significant difference in BP response compared with those with a lower sleepiness score. Receiver-operating characteristic (ROC) curve analyses investigating the accuracy of AHI and ESS to predict a BP reduction at least 5 mmHg revealed an AUC of 0.51 and 0.52, respectively.
The study confirms that CPAP therapy for sleep apnea has a mild BP lowering effect. Although this effect is slightly higher in patients with above-average AHI, neither AHI nor ESS can be used to define threshold values predicting a BP decrease at least 5 mmHg.
睡眠呼吸暂停与高血压有关。荟萃分析表明,持续气道正压通气(CPAP)治疗睡眠呼吸暂停可使血压平均降低 3mmHg。迄今为止,CPAP 治疗血压反应的预测因素仍不完全清楚。我们假设 CPAP 诱导的血压降低幅度取决于基线呼吸暂停低通气指数(AHI)和白天嗜睡程度。
我们对 2461 例阻塞性睡眠呼吸暂停患者的 CPAP 治疗与多导睡眠图读数、嗜睡程度(Epworth 嗜睡量表,ESS)以及流行病学参数之间的 BP 反应相关性进行了回顾性研究。BP 反应定义为多导睡眠图检查前后诊室 BP 的差异。
555 例患者符合所有纳入和排除标准,并纳入分析。中位每月 CPAP 使用时间为 143.7 小时(85.4-204.1 小时)。与随访时相比,基线时血压明显升高(129.9±15.5 与 128.3±15.2,P=0.021),导致 BP 平均降低-1.5±19.2mmHg。基线 AHI 高于中位数(中位数 21)的患者比 AHI 较低的患者血压降低更明显(AHI>21:130.5±15.3 与 128.6±14.6,P=0.06;AHI<21:129.5±15.8 与 127.9±15.8,P=0.18)。CPAP 治疗可显著降低嗜睡程度(8.3±4.8 与 6.6±4.5,P<0.0001)。然而,与嗜睡程度较低的患者相比,ESS 高于中位数(ESS≥8)的患者血压反应无显著差异。评估 AHI 和 ESS 预测 BP 降低至少 5mmHg 的准确性的受试者工作特征(ROC)曲线分析显示 AUC 分别为 0.51 和 0.52。
该研究证实 CPAP 治疗睡眠呼吸暂停具有轻度降压作用。尽管 AHI 高于平均水平的患者这种作用略高,但 AHI 和 ESS 均不能用于定义预测 BP 降低至少 5mmHg 的阈值值。